Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection.
about
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistanceA2 gene of Old World cutaneous Leishmania is a single highly conserved functional gene.Determinants for the development of visceral leishmaniasis diseaseDevelopment of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasisComparative Life Cycle Transcriptomics Revises Leishmania mexicana Genome Annotation and Links a Chromosome Duplication with Parasitism of VertebratesLeishmania tarentolae molecular signatures in a 300 hundred-years-old human Brazilian mummyPostgenomic research on leishmaniasis: a critical self-appraisalA genomic-based approach combining in vivo selection in mice to identify a novel virulence gene in Leishmania.Temperature increase prevails over acidification in gene expression modulation of amastigote differentiation in Leishmania infantum.Genetically modified organisms and visceral leishmaniasisBiomarkers of safety and immune protection for genetically modified live attenuated leishmania vaccines against visceral leishmaniasis - discovery and implications.Genetic analysis of Leishmania donovani tropism using a naturally attenuated cutaneous strain.Characterization of a Leishmania stage-specific mitochondrial membrane protein that enhances the activity of cytochrome c oxidase and its role in virulenceLeishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependentDoes the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?A genomic scale map of genetic diversity in Trypanosoma cruzi.Comparative in-silico genome analysis of Leishmania (Leishmania) donovani: A step towards its species specificity.Transmembrane molecules for phylogenetic analyses of pathogenic protists: Leishmania-specific informative sites in hydrophilic loops of trans- endoplasmic reticulum N-acetylglucosamine-1-phosphate transferase.Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis.The Leishmania metaphylome: a comprehensive survey of Leishmania protein phylogenetic relationshipsGenome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex.Cutaneous Infection with Leishmania major Mediates Heterologous Protection against Visceral Infection with Leishmania infantumHisAK70: progress towards a vaccine against different forms of leishmaniosis.Mitigating an undesirable immune response of inherent susceptibility to cutaneous leishmaniosis in a mouse model: the role of the pathoantigenic HISA70 DNA vaccine.Role of cytosolic glyceraldehyde-3-phosphate dehydrogenase in visceral organ infection by Leishmania donovaniLive attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB/c mice.The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist.Transgenic Leishmania and the immune response to infectionApplication of Recombinant Proteins for Serodiagnosis of Visceral Leishmaniasis in Humans and Dogs.Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures.Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites.Identification of internalin-A-like virulent proteins in Leishmania donovani.Whole genome sequencing of live attenuated Leishmania donovani parasites reveals novel biomarkers of attenuation and enables product characterization.Expression of a recombinant protein, A2 family, from Leishmania infantum (Jaboticabal strain) and its evaluation in Canine Visceral Leishmaniasis serological test.Molecular Analysis of A2-genes Encoding Stage-specific S Antigen-like Proteins among Isolates from Iranian Cutaneous and Visceral LeishmaniasisOptimized CRISPR-Cas9 Genome Editing for Leishmania and Its Use To Target a Multigene Family, Induce Chromosomal Translocation, and Study DNA Break Repair Mechanisms.A common mechanism of stage-regulated gene expression in Leishmania mediated by a conserved 3'-untranslated region element.Identification and characterization of a protein-tyrosine phosphatase in Leishmania: Involvement in virulence.Cationic solid-lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice.Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae.
P2860
Q24633552-D4CE3175-E629-4922-B40B-24F88CCA6FDCQ24811684-41CBE89E-3BA5-49BB-BE20-203F24C99297Q27027871-25175F58-01F5-48E9-8B9C-602094A3E2FDQ28486287-D279D013-31BB-4559-85A2-22E0C4CDAB6CQ28550169-C4DDF3DE-1539-4D32-B2AB-632BF53424DFQ28649928-556A3A7B-A8E3-4BD5-A276-4A64D0BAD960Q28748982-5510A814-7014-4AEB-AFEB-ED9882013912Q33342808-A96FA5B9-AB82-44B2-8A59-18E3B6E2DDE6Q33523892-47F2A429-BF96-4868-B945-F22F26834C8BQ33647026-F5CDFF5F-78F6-4089-87D1-EC0E0BE5D817Q33659753-609C0D2A-0879-4077-B053-CA9CB039D42DQ33846006-349E172D-9203-4D62-BA7E-95AE079C4500Q34017302-C99CCFB3-1106-4367-A7AA-C5AD1C57E41EQ34127073-735E42DE-EA91-4777-AAB7-E806E73FB5C0Q34347500-E3762AB4-462D-498C-9D2E-C86E84A6C5B9Q34523989-88CDA8E6-C20C-4321-BF50-F9C9E4881B6EQ34879257-9C190645-2475-4661-AFD6-AFA7DBC4578CQ35636496-7D40D762-E158-48A6-8BBB-B7A99AA3C27EQ35673111-6EC9FEC9-876F-4139-847A-3914CE74929EQ35827646-A6B33C66-196D-4106-A380-0F30B3EF52C8Q35861438-25D5791D-853A-4887-9701-C5414E3D2374Q36331305-145DA623-A960-4DA1-848B-2D168AC0E6DEQ36361604-29415438-323C-423E-975C-36D2817386F8Q36415941-8A90686B-61F7-4A6B-B044-F3F1A3DB930DQ36505121-E0C9AA46-A369-43DC-A858-F6A0559FA5C8Q36625975-507D5227-1C7B-499D-B2FD-9AFC0A66AD85Q36837840-7FBF3F67-C97C-4A56-823D-226F85BBB45EQ37081691-0A67D050-076A-4A76-95D8-7D3AF8DE97A1Q37106269-DA2EBB67-3411-4D0D-A28E-7F6A1F01365FQ37123434-CFC27FBA-B9D8-4711-988B-281CD4F587A7Q38342966-2ACF8230-EF09-482B-B0B7-B1743BA2F7C2Q40495564-7D7ABF90-A8E7-4F2F-A2A1-465C7A22FD48Q40957138-F1214ABA-071C-4A4F-8221-7B146EC288E8Q40962887-D10CA0BA-6AED-4139-AF87-CE2840F1DDA0Q41813320-EE88EEBB-CC9E-42E0-B948-35EBC55F5B0AQ42329832-3C3750D5-610D-4D31-8480-3E0707875E86Q42672872-45D8B0EC-ED02-4929-8AE3-2E7491865A5DQ43636703-ED6D3B80-DB80-44B8-92ED-83687E767F38Q44390690-6290E292-3B91-4002-9F93-A086CF2FCB8DQ46024984-1E28C072-601E-43FC-9530-25EDA30E1BFA
P2860
Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Characterization of the A2-A2r ...... ceralization during infection.
@en
Characterization of the A2-A2r ...... ceralization during infection.
@nl
type
label
Characterization of the A2-A2r ...... ceralization during infection.
@en
Characterization of the A2-A2r ...... ceralization during infection.
@nl
prefLabel
Characterization of the A2-A2r ...... ceralization during infection.
@en
Characterization of the A2-A2r ...... ceralization during infection.
@nl
P2860
P921
P1476
Characterization of the A2-A2r ...... ceralization during infection.
@en
P2093
Matlashewski G
P2860
P304
P356
10.1046/J.1365-2958.2001.02286.X
P407
P577
2001-02-01T00:00:00Z